Regeneron Announces Investor Conference Presentations
January 31 2023 - 3:01PM
Regeneron Pharmaceuticals, Inc. (NASDAQ:
REGN)
will webcast management participation as follows:
- SVB Securities Global Biopharma Conference at 9:20 a.m. ET on
Tuesday, February 14, 2023
- Cowen 43rd Annual Health Care Conference at 12:50 p.m. ET on
Monday, March 6, 2023
- Oppenheimer 33rd Annual Healthcare Conference at 9:20 a.m. ET
on Monday, March 13, 2023
- Barclays Global Healthcare Conference at 9:00 a.m. ET on
Wednesday, March 15, 2023
The sessions may be accessed from the "Investors
& Media" page of Regeneron's website at
https://investor.regeneron.com/events-and-presentations. Replays of
the webcasts will be archived on the Company's website for at least
30 days.
About Regeneron Regeneron
(NASDAQ: REGN) is a leading biotechnology company that invents,
develops and commercializes life-transforming medicines for people
with serious diseases. Founded and led for 35 years by
physician-scientists, our unique ability to repeatedly and
consistently translate science into medicine has led to nine
FDA-approved treatments and numerous product candidates in
development, almost all of which were homegrown in our
laboratories. Our medicines and pipeline are designed to help
patients with eye diseases, allergic and inflammatory diseases,
cancer, cardiovascular and metabolic diseases, pain, hematologic
conditions, infectious diseases and rare diseases.
Regeneron is accelerating and improving the
traditional drug development process through our proprietary
VelociSuite® technologies, such as VelocImmune®, which uses unique
genetically humanized mice to produce optimized fully human
antibodies and bispecific antibodies, and through ambitious
research initiatives such as the Regeneron Genetics Center, which
is conducting one of the largest genetics sequencing efforts in the
world.
For more information, please visit
www.Regeneron.com or follow @Regeneron on Twitter.
Contact Information: Investor
Relations Ryan Crowe 914.847.8790 ryan.crowe@regeneron.com
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2024 to May 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From May 2023 to May 2024